DMPHF Income Statement - TTM - Dermapharm Holding SE

Income Statement (TTM)

Dermapharm Holding SE Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	775	808	828	858	902	960	980	1,004	1,024	1,041	1,128	1,151	1,172	1,151	1,129	1,147	1,174	1,195	1,199	1,191
Change (%)		4.29	2.46	3.62	5.14	6.41	2.08	2.43	2.01	1.61	8.37	2.09	1.80	-1.81	-1.86	1.54	2.37	1.83	0.32	-0.69
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	347	354	347	342	345	350	357	372	386	392	413	433	442	447	438	434	440	446	449	435
Change (%)		2.03	-2.05	-1.59	0.86	1.54	1.95	4.33	3.73	1.51	5.46	4.68	2.07	1.15	-1.85	-1.05	1.36	1.36	0.87	-3.14
% of Revenue	44.82	43.85	41.92	39.81	38.19	36.44	36.39	37.07	37.69	37.66	36.64	37.57	37.67	38.81	38.81	37.82	37.45	37.27	37.48	36.55

Gross Operating Profit	428	454	481	517	558	610	623	632	638	649	714	719	730	704	691	713	734	750	750	756
Change (%)		6.13	5.98	7.38	7.97	9.42	2.16	1.34	0.99	1.67	10.14	0.59	1.64	-3.60	-1.87	3.18	2.99	2.12	-0.00	0.78
% of Revenue	55.18	56.15	58.08	60.19	61.81	63.56	63.61	62.93	62.31	62.34	63.36	62.43	62.33	61.19	61.19	62.18	62.55	62.73	62.52	63.45

SG&A	142	158	168	167	168	169	173	180	185	191	212	228	249	271	274	282	283	287	294	295
Change (%)		11.16	6.28	-0.39	0.36	0.60	2.11	4.60	2.25	3.28	11.42	7.41	9.23	8.79	1.19	2.85	0.25	1.65	2.13	0.53
% of Revenue	18.35	19.55	20.28	19.50	18.61	17.60	17.60	17.98	18.02	18.31	18.83	19.81	21.26	23.55	24.28	24.60	24.09	24.04	24.48	24.78

R&D
Change (%)
% of Revenue

OpEx	636	668	678	677	682	664	679	705	752	758	826	896	920	958	953	949	960	973	980	961
Change (%)		5.06	1.52	-0.24	0.84	-2.67	2.22	3.84	6.60	0.84	8.96	8.51	2.64	4.13	-0.50	-0.35	1.07	1.44	0.69	-1.94
% of Revenue	82.06	82.66	81.91	78.86	75.63	69.18	69.27	70.22	73.39	72.83	73.22	77.83	78.47	83.21	84.37	82.79	81.74	81.42	81.72	80.70

Operating Income	139	140	150	181	220	296	301	299	273	283	302	255	252	193	177	197	214	222	219	230
Change (%)		0.79	6.93	21.09	21.16	34.61	1.78	-0.75	-8.82	3.73	6.82	-15.48	-1.14	-23.45	-8.60	11.76	8.67	3.58	-1.28	4.87
% of Revenue	17.94	17.34	18.09	21.14	24.37	30.82	30.73	29.78	26.61	27.17	26.78	22.17	21.53	16.79	15.63	17.21	18.26	18.58	18.28	19.30

Interest Expense	-10	-9	-9	-9	-9	-9	-9	-9	-9	-12	-24	-33	-49	-55	-57	-59	-58	-58	-56	-53
Change (%)		-3.56	-2.95	-2.60	1.08	-1.22	0.01	-1.31	0.88	40.22	93.25	37.96	47.99	12.92	3.38	3.96	-1.81	0.68	-4.47	-4.16
% of Revenue	-1.25	-1.16	-1.10	-1.03	-0.99	-0.92	-0.90	-0.87	-0.86	-1.19	-2.11	-2.86	-4.15	-4.78	-5.03	-5.15	-4.94	-4.89	-4.65	-4.49

Net Income	80	86	95	123	162	210	211	185	176	134	146	123	95	62	57	83	91	114	104	107
Change (%)		7.26	11.24	29.17	31.75	28.99	0.51	-12.01	-5.05	-23.73	8.96	-16.21	-22.53	-34.32	-9.28	46.75	9.09	25.61	-8.98	3.50
% of Revenue	10.32	10.62	11.53	14.37	18.01	21.83	21.49	18.46	17.19	12.90	12.97	10.65	8.10	5.42	5.01	7.24	7.72	9.52	8.64	9.00

Source: Capital IQ

AT:DMP
DE:DMP
GB:DMPD
GB:0A5J

Dermapharm Holding SE - Income Statement (TTM)

Income Statement (TTM)

Other Listings